UNITED THERAPEUTICS Corp SEC filings UTHR
UNITED THERAPEUTICS Corp has 1,005 filings in SEC EDGAR's recent list, going back to Apr 7, 2023. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SD | Specialized disclosure (conflict minerals) | Jun 2, 2026 | — |
| SD | Specialized disclosure (conflict minerals) | May 30, 2025 | — |
| SD | Specialized disclosure (conflict minerals) | May 31, 2024 | — |
| SC TO-T/A | Filing | Dec 13, 2023 | — |
| CORRESP | Letter to the SEC | Dec 13, 2023 | — |
| SC TO-T/A | Filing | Dec 12, 2023 | — |
| SC TO-T/A | Filing | Dec 4, 2023 | — |
| SC TO-T | Filing | Nov 13, 2023 | — |
| SC TO-C | Filing | Nov 1, 2023 | — |
| SC TO-C | Filing | Oct 30, 2023 | — |
| SC TO-C | Filing | Oct 30, 2023 | — |
| SD | Specialized disclosure (conflict minerals) | May 31, 2023 | — |
Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- UTHR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Silver Spring, MD
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1082554
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.